The son of a man who died from uncontrollable internal bleeding after taking Xarelto has filed a lawsuit against the drug’s manufacturers, Bayer Healthcare and Janssen Pharmaceuticals. Danny Julien filed the Xarelto lawsuit after his father began taking the anticoagulant to reduce risk of stroke; he died a few months later.
The U.S. Food and Drug Administration approved Xarelto in 2011 for patients who are at an increased risk of stroke due to non-valvular atrial fibrillation or at a risk for blood clots after knee or hip replacement surgery. Shortly after its approval, hundreds of patients began reporting Xarelto side effects.
Xarelto has been linked to an increased risk of internal bleeding, blood clots and other severe complications. The drug does not contain a natural antidote, which makes it difficult for doctors to control excessive bleeding or hemorrhaging due to the drug.